CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-10 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,500 | 0 | ||
| 2025-02-27 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +27,402 | 27,402 | ||
| 2025-02-27 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +22,098 | 22,098 | ||
| 2025-02-27 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +42,900 | 42,900 | ||
| 2025-02-27 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +34,650 | 34,650 | ||
| 2025-02-27 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +105,649 | 105,649 | ||
| 2025-02-27 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +85,201 | 85,201 | ||
| 2025-02-27 | KIES PETER CFO | Grant or award · Common Stock Option | +39,050 | 39,050 | ||
| 2025-02-27 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +31,900 | 31,900 | ||
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +3,855 | 28,192 | ||
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −1,584 | $1.98 | $3K | 26,608 |
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +5,010 | 31,618 | ||
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −2,059 | $1.98 | $4K | 29,559 |
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −3,855 | 0 | ||
| 2025-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −5,010 | 10,019 | ||
| 2025-02-26 | Sumner Michael John Chief Medical Officer | Option exercise | +5,010 | 13,229 | ||
| 2025-02-26 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −5,010 | 10,019 | ||
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +5,852 | 39,499 | ||
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −2,493 | $1.98 | $5K | 37,006 |
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +18,632 | 55,638 |
Page 7 of 17 · 322 trades